Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Liraglutide or Insulin in Real Life Usage in Patients With Diabetes Mellitus Type 2

NCT01484262 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT01484262
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01484262 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Liraglutide or Insulin in Real Life Usage in Patients With Diabetes Mellitus Type 2
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
November 14, 2011
Completion date
October 31, 2014
Enrollment
1,344 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 2